InMed Pharmaceuticals Inc (INM)

[Matilda1]

Duh... what kind of dilution are we going to suffer to get even close to the last financing? I still remember Adams “mocking laughter” at the thought of warrants being exercised. This company will have a hard time attracting investors for another round of FAILURE! Might I remind you of the numbers from the last round... and what are they going to need this time to buy another couple years?... when they’re not even close to commercial production!


Under the terms of the Financing, the Company issued a total of 16,611,244 units (the "Units") at a price per Unit of C$0.90, inclusive of the Units offered in the over-allotment. The Units were offered and issued pursuant to the filing of a prospectus supplement to the Company's short form base shelf prospectus dated September 11, 2017 (together, the "Prospectus"), filed in the provinces of British Columbia, Alberta and Ontario. Each Unit consists of one common share of the Company (a "Share") and one common share purchase warrant (a "Warrant"). Each Warrant entitles the holder thereof to acquire one additional Share at a price of C$1.25 for a period of 24 months following the closing date, or June 21, 2020.